ENGN
enGene Holdings Inc. Common Stock
NASDAQ: ENGN · HEALTHCARE · BIOTECHNOLOGY
$7.27
+3.27% today
Updated 2026-04-30
Market cap
$535.25M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$3 – $12
Volume
0.4M
enGene Holdings Inc. Common Stock (ENGN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-46.10%
ROA
-25.60%
Debt/equity
0.19x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2020 | $0.00 | $-15.07M | — | — | — |
| 2021 | $0.00 | $-23.44M | — | — | — |
| 2022 | $0.00 | $-24.46M | — | — | — |
| 2023 | $0.00 | $-99.92M | — | — | — |
| 2024 | $0.00 | $-55.14M | — | — | — |
| 2025 | $0.00 | $-117.30M | — | — | — |